Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|May 26, 2010

Diagnostic Imaging

  • Diagnostic Imaging Vol 32 No 5
  • Volume 32
  • Issue 5

PET/CT detects colorectal cancer recurrences

PET/CT scans can confirm a suspected colorectal cancer recurrence at an early stage, helping significantly in treatment, according to a study presented at the ARRS annual meeting.

PET/CT scans can confirm a suspected colorectal cancer recurrence at an early stage, helping significantly in treatment, according to a study presented at the ARRS annual meeting.

Researchers at The Christie NHS Foundation Trust in Manchester, U.K., found 71 patients with suspected co-lorectal recurrence. Suspicion was based on CT and MR in 51 cases. The rest had a suspected recurrence based on a carcinoembryonic antigen test with unremarkable conventional imaging.

All 71 patients had a PET/CT scan to confirm or negate recurrence. The modality accurately confirmed a recurrence in 40 of 71 patients.

“This shows that PET/CT has a definite role in the management of patients with recurrent colorectal cancer in addition to conventional imaging and the CEA test,” said Dr. Rohit Kochhar, lead author of the study.


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.